1246818-88-1: Atorvastatin Oxirane Impurity

1246818-88-1: Atorvastatin Oxirane Impurity

It is used in the treatment of coronary heart disease. it reduces the risk of nonfatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalizations for congestive heart failure, and angina.

Additional information on CAS 1246818-88-1

Catalogue No.

VL10032
CAS No.

1246818-88-1
Molecular Formula

C₂₆H₂₄FNO₃
Molecular Weight

417.47
Parent drug

Atorvastatin
IUPAC Name

3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyloxirane-2-carboxylic Acid Phenylamide
Synonyms

N/A
References

McIver, Lindsey A., and Momin S. Siddique. Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, http://www.ncbi.nlm.nih.gov/books/NBK430779/. Black, Donald M., et al. An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor.” Archives of Internal Medicine, vol. 158, no. 6, Mar. 1998, p. 577, https://doi.org/10.1001/archinte.158.6.577.
Status

In-stock

Other products related to atorvastatin

Request a quote

1246818-88-1: Atorvastatin Oxirane Impurity

1246818-88-1: Atorvastatin Oxirane Impurity
Catalogue No.

VL10032
CAS No.

1246818-88-1
Molecular Formula

C₂₆H₂₄FNO₃
Molecular Weight

417.47
Parent drug

Atorvastatin
IUPAC Name

3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyloxirane-2-carboxylic Acid Phenylamide
Synonyms

N/A
References

McIver, Lindsey A., and Momin S. Siddique. Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, http://www.ncbi.nlm.nih.gov/books/NBK430779/. Black, Donald M., et al. An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor.” Archives of Internal Medicine, vol. 158, no. 6, Mar. 1998, p. 577, https://doi.org/10.1001/archinte.158.6.577.
Status

In-stock
ListName

Atorvastatin Oxirane Impurity
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url